"American Cancer Society (ACS)" "CancerCare" "AVONCares Program for Women" "Cancer Candlelighters" "Childhood Cancer Foundation (CCCF)" "Leukemia and Lymphoma Society (LLS)" "Patient Advocate Foundation (PAF)" "Patient Assistance Programs (PAPs)" "Road to Recovery Medicare Children's Health Insurance Program (CHIP)" "Veteran Administration (VA)" "Hill-Burton" "Ask about tax deductions for people with cancer" "Partnership for Prescription Assistance" (more to come)
Pembrolizumab is an investigational immunotherapy that may help the body’s immune system attack cancer cells. When a cancer cell binds to an immune cell, the immune cell can’t do its job. These trials want to see if pembrolizumab can block cancer cells from binding with immune cells to help allow the immune cells to work properly.
Participating in a clinical trial is an important decision. Anyone participating in a trial should know as much as possible about what is being studied, what risks are involved and what potential benefits may be gained before deciding to enroll. If you are interested in participating in a clinical trial, please talk to your doctor first.
You can also call our clinical trial information center at 1-888-577-8839 to learn more.